Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Human Bone Marrow-Derived Mesenchymal (Stromal) Progenitor Cells (MPCs) Cannot Be Recovered from Peripheral Blood Progenitor Cell Collections
1997
The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry
1996 Standout
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
2001 Standout
5 Treatment and prognostic factors in acute myeloid leukaemia
1996
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
The FGF family: biology, pathophysiology and therapy
2009 Standout
Stem cells from bone marrow, umbilical cord blood and peripheral blood for clinical application: current status and future application
1996
Chemokines and leukocyte traffic
1998 StandoutNature
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
2002 Standout
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Psychometric evaluation of the pittsburgh sleep quality index
1998 Standout
Evaluation of Conflict of Interest in Economic Analyses of New Drugs Used in Oncology
1999
The tissue inhibitor of metalloproteinases-1 improves migration and adhesion of hematopoietic stem and progenitor cells
2013 StandoutNobel
Large quantity production with extreme convenience of human SDF‐1α and SDF‐1β by a Sendai virus vector
1998 StandoutNobel
Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction
2006 Standout
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients
2003 Standout
Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
2004
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
2008 Standout
Outpatient tonsillectomy and adenoidectomy clinical pathways: an evaluative study
1998
Early Phase I/II Trials with Gemtuzumab Ozogamicin (Mylotarg®) in Acute Myeloid Leukemia
2002
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Chronic myelogenous leukemia: A review
1996
Cisplatin chemotherapy (without erythropoietin) and risk of life-threatening thromboembolic events in carcinoma of the uterine cervix: the tip of the iceberg? A review of the literature
2006
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
1998 StandoutNature
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
2013 Standout
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings
2006 Standout
Pharmacokinetic evaluation of high-dose etoposide phosphate after a 2-hour infusion in patients with solid tumors
1996
Graft-versus-host disease
2009 Standout
Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumors.
1994
[27] The signal sequence trap method
1999 StandoutNobel
Hematopoietic Stem-Cell Transplantation
2006 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Cancer treatment and survivorship statistics, 2012
2012 Standout
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Fatigue in long-term survivors of Hodgkin‘s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG)
2003
Quality of life following bone marrow transplantation: findings from a multicentre study
1995
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.
1994
Quality of life of 125 adults surviving 6–18 years after bone marrow transplantation
1995
The colony-stimulating factors and cancer
2010
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Neutrophils in cancer: neutral no more
2016 Standout
A review of autologous hematopoietic cell transplantation
2000 Nobel
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Mixed chimerism and immunosuppressive drug withdrawal after hla-mismatched kidney and hematopoietic progenitor transplantation1
2002
Presentation of Epstein-Barr virus latency antigens to CD8+, interferon-γ-secreting, T lymphocytes
1999 StandoutNobel
Scope and Impact of Financial Conflicts of Interest in Biomedical Research
2003 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
NK CELL RECOGNITION
2004 Standout
Chemokines
1997 Standout
Proliferating dendritic cell progenitors in human blood.
1994 StandoutNobel
Cytokines, platelet production and hemostasis
1997
Health-Related Quality of Life 1 Year After Allogeneic or Autologous Stem-Cell Transplantation: A Prospective Study
1999
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease.
1999
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
2000
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Genetic Control of Human NK Cell Repertoire
2002
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage
1998 StandoutNobel
Granulocyte Colony-Stimulating Factor Reduces the Capacity of Blood Mononuclear Cells to Induce Graft-Versus-Host Disease: Impact on Blood Progenitor Cell Transplantation
1997
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study
2004
Peripheral blood stem cells reach new heights [editorial; comment]
1993
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma
2003
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
1997
Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy
2000 Standout
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood
1997
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice
1998 Standout
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Plasma elevation of stromal cell–derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells
2001 StandoutNobel
Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs
2010 Standout
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Cytokine-induced radiation protection and sensitization
1996
Works of GD Long being referenced
Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease.
1991
Dynamic assessment of quality of life after autologous bone marrow transplantation
1992
Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
1997
Critical pathway for administering high-dose chemotherapy followed by peripheral blood stem cell rescue in the outpatient setting.
1995
Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia
1993
Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission
1993
Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy
1993
Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma
1995
Dynamic assessment of quality of life after autologous bone marrow transplantation
1992
Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission
1993
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase
1994